Introduction {#s1}
============

Protein evolution is rife with examples of structural and functional domains utilized by multiple proteins: for example, over 700 human proteins display SH3 domains, and over 450 proteins display PDZ domains. The identification of such common domains may hint at similarities in substructure, interactions, and potentially in function, for the various proteins displaying these domains. About 680 different domains have been documented to date in the proteomes of humans and other organisms (SMART database, <http://smart.embl-heidelberg.de/>, [@pone.0000463-Letunic1]), and many of these domains appear, with some variation, in numerous proteins. Alternatively, the recognition of novel motifs may link proteins previously thought to be unrelated---e.g., suggesting a common function or interaction---and therefore may aid in the determination of both structure and function for proteins that display the novel motif.

We have previously described a set of receptors that induces apoptosis following ligand withdrawal, but inhibits apoptosis following the binding of trophic ligands [@pone.0000463-Bredesen1]--[@pone.0000463-Bredesen2]. These receptors have been referred to as dependence receptors. Such receptors play roles in neural development, tumorigenesis (including metastasis), neurodegeneration, and possibly in subapoptotic events such as neurite retraction and somal atrophy [@pone.0000463-Bredesen1]--[@pone.0000463-Bredesen2].

To date, ten such receptors have been described ([Table 1](#pone-0000463-t001){ref-type="table"} and [@pone.0000463-Bredesen1]). These do not share any obvious structural similarity, nor do they display similar domains required for apoptosis induction. For example, Unc5H2 features a death domain in its intracytoplasmic region, but DCC does not; instead, apoptosis induction by DCC requires a short region in its intracytoplasmic domain (residues 1243--1264) that does not bear similarity to a death domain.

10.1371/journal.pone.0000463.t001

###### Ten dependence receptors (plus orthologues) comprise the training set for the MEME query.

![](pone.0000463.t001){#pone-0000463-t001-1}

  Entry Name    Accession \#/Species                       Protein Name                             TM Location          DART Location            Subcellular Location                                                            Function (per Swiss-Prot)
  ------------ ---------------------- ------------------------------------------------------ -------------------------- --------------- ----------------------------------------- --------------------------------------------------------------------------------------------------------------------------
  A4               P05067 (Human)                    Amyloid beta A4 protein                          700-723               705-723              Type I membrane protein                                                Mutated in some cases of Alzheimer\'s Disease
                    P79307 (Pig)                                                                                                                                                  
                   P12023 (Mouse)                                                                                                                                                 
                   Q6RH29 (Canfa)                                                                                                                                                 
  ANDR             P10275 (Human)                       Androgen receptor                     690-919 (ligand-binding)      880-898                      Nuclear                                                  Regulation of eukaryotic gene expression in target tissues
                    Q9GKL7 (Pig)                                                                                                                                                  
                   P19091 (Mouse)                                                                                                                                                 
                  P49699 (Rabbit)                                                                                                                                                 
  DCC              P43146 (Human)                      Netrin receptor DCC                           1098-1122             1098-1116             Type I membrane protein                                                Receptor for netrin required for axon guidance
                   P70211 (Mouse)                                                                                                                                                 
                    Q63155 (Rat)                                                                                                                                                  
                   Q91562 (Xeno)                                                                                                                                                  
  PTC1             Q13635 (Human)                   Patched protein homolog 1                       **101-121**             101-119             Integral membrane protein          Receptor for sonic hedgehog (SHH), indian hedgehog (IHH) and desert hedgehog (DHH). May have a tumor suppressor function
                   Q61115 (Mouse)                                                                     437-457               574-592                                               
                   Q90693 (Chick)                                                                     473-493              1029-1047                                              
                   Q09614 (Caeel)                                                                     502-522              1085-1103                                              
                                                                                                      548-568                                                                     
                                                                                                    **578-598**                                                                   
                                                                                                      749-769                                                                     
                                                                                                   **1028-1048**                                                                  
                                                                                                     1056-1076                                                                    
                                                                                                   **1084-1104**                                                                  
                                                                                                     1122-1141                                                                    
                                                                                                     1155-1175                                                                    
  RET              P07949 (Human)      Proto-oncogene tyrosine-protein kinase receptor ret            636-657               637-655              Type I membrane protein                                     Part of GDNF receptor complex with tyrosine-protein kinase activity
                   P35546 (Mouse)                                                                                                                                                 
                    Q9EPA1 (Rat)                                                                                                                                                  
                   O42362 (Brare)                                                                                                                                                 
  TNR5             P25942 (Human)      Tumor necrosis factor receptor superfamily member 5            194-215               195-213              Type I membrane protein                                                          Receptor for TNFSF5/CD40L
                   P27512 (Mouse)                                                                                                                                                 
                  Q28203 (Bovine)                                                                                                                                                 
                   Q7YRL5 (Canfa)                                                                                                                                                 
  TNR16            P08138 (Human)      Tumor necrosis factor receptor superfamily member 16           251-272               257-275              Type I membrane protein                                                         Common neurotrophin receptor
                    P07174 (Rat)                                                                                                                                                  
                   Q9Z0W1 (Mouse)                                                                                                                                                 
                   P18519 (Chick)                                                                                                                                                 
  UNC5A            Q6ZN44 (Human)                     Netrin receptor UNC5A                           307-327               309-327              Type I membrane protein                                                Receptor for netrin required for axon guidance
  UNC5B            Q8IZJ1 (Human)                     Netrin receptor UNC5B                           378-398               381-399      Type I membrane protein (by similarity)                               Receptor for netrin required for axon guidance (axon repulsion)
  UNC5C            O95185 (Human)                     Netrin receptor UNC5C                           381-401               382-400      Type I membrane protein (by similarity)                                  Receptor for netrin required for axon guidance (repulsion)
                   O08747 (Mouse)                                                                                                                                                 

Ten dependence receptors plus their orthologues (32 sequences total) were used as a training set by the MEME program to search for high-scoring motifs common to all proteins. [Table 1](#pone-0000463-t001){ref-type="table"} shows the transmembrane location (for each protein with one) and the location of the DART motif. Data taken from the Swiss-Prot database. All accession numbers are from Swiss-Prot.

In the present study, we attempted to determine whether dependence receptors as a group may indeed display a common motif(s) that had gone undetected by the initial comparisons of alignment and predicted (known) domains. We utilized the Multiple EM (Expectation Maximization) for Motif Elicitation program (MEME) (<http://meme.sdsc.edu/meme/meme.html> and [@pone.0000463-Bailey1]) and identified a novel motif that is featured by receptors that have been described as dependence receptors. We then searched the Swiss-Prot protein database (<http://www.expasy.uniprot.org/> and [@pone.0000463-Boeckmann1]) using the Motif Alignment and Search Tool (MAST) program (<http://meme.sdsc.edu/meme/mast.html> and [@pone.0000463-Bailey2]), to determine whether other receptors or other proteins also feature this motif, and identified an additional 16 human proteins that display this motif (see [Results](#s3){ref-type="sec"} and Discussion, below).

The novel putative motif is in a transmembrane region, and therefore was dubbed dependence-associated receptor transmembrane motif (DART motif). Here we describe the consensus sequence and discuss the possible functions of this novel motif.

Materials and Methods {#s2}
=====================

Databases and software {#s2a}
----------------------

The UniProt Knowledgebase (UniProtKB; <http://www.expasy.uniprot.org/>) database Release 3.3 (consisting of Swiss-Prot Release 45.3 and TrEMBL Release 28.3) from the Swiss Institute of Bioinformatics was used for this study. This database was chosen because it is well documented and allowed us to analyze the predictions on receptors.

The MEME (<http://meme.sdsc.edu/meme/meme.html>) software program (version 3.0; non-commercial version) was used for the identification of motifs in non-aligned sequences, where a motif is a sequence pattern that occurs repeatedly in a group of protein or DNA sequences. MEME saves these motifs as a set of profiles. MEME uses the method of Bailey and Elkan to identify likely motifs within the input set of sequences [@pone.0000463-Bailey1]. A range of motif widths (\>15 amino acids in length) and various numbers of unique motifs to search for (zero or one motifs per sequence) were specified in our queries.

The software program MAST (<http://meme.sdsc.edu/meme/mast.html>, version 3.0; non-commercial version) was used to search the Swiss-Prot database for other proteins displaying the motifs identified by MEME to be present in more than one dependence receptor. The algorithm in MAST calculates position scores for each profile at each possible position within a sequence. These scores are translated into p-values, which represent the likelihood of the given profile scoring that well against a randomly generated sequence. The best (i.e., lowest) position p-values for each profile are then adjusted to take into account the length of the sequence. MAST avoids allowing gaps in the profiles or in the search sequence.

Training Set {#s2b}
------------

In order to search for motifs in previously described dependence receptors, we used a set of ten human receptors and their corresponding orthologues (three orthologues were used for each, in order to avoid bias generated by using more orthologues for one dependence receptor than another) found in the UniProtKB database. Thus, our training set included a total of 32 protein sequences (32 rather than 40, since the netrin receptors Unc5A, Unc5B, Unc5C were represented by a total of 4 sequences rather than 12, to prevent overweighting). This list is shown in [Table 1](#pone-0000463-t001){ref-type="table"}.

The option of having the training set sequences "shuffled" provided one of the controls used, ensuring that the motif(s) we detected were significant.

Web Site {#s2c}
--------

To maintain updated information on the dependence receptor field and to allow researchers to identify the DART motif in their protein of interest, we have developed a website (<http://bis.ifc.unam.mx/DependenceReceptors/>). The program at our website runs four independent predictions: three for identifying a transmembrane region and one for identifying the DART motif. The transmembrane region predictions are run through three different programs located at:

1.  HMMTOP (<http://www.enzim.hu/hmmtop/>),

2.  SOSUI (<http://sosui.proteome.bio.tuat.ac.jp/sosui_submit.html>) and

3.  TMPRED (<http://www.ch.embnet.org/software/TMPRED_form.html>).

For identifying the DART motif, the website uses the MAST program.

Results {#s3}
=======

Searching for motifs among the known dependence receptors {#s3a}
---------------------------------------------------------

The dependence receptors listed in [Table 1](#pone-0000463-t001){ref-type="table"} have all been shown to induce programmed cell death when expressed in the absence of their respective trophic ligands, but not when bound by these same trophic ligands. The receptors\' non-orthologous sequences in the training set did not show any significant sequence similarity by simple alignment searches. Hence, in order to search for novel motifs in this set, we used the MEME program. MEME allows the identification of motifs in non-aligned sequences, where a motif is a sequence pattern that occurs repeatedly in a group of protein or DNA sequences (see [Materials and Methods](#s2){ref-type="sec"} section). Although MEME has been most commonly used to identify motifs in homologous sequences, a pattern identified by MEME in non-homologous sequences may be biologically relevant if: a) the proteins in the training set share a common function and b) the proteins identified to contain the motif could reasonably be suspected to share functional features with the training set. Note that these are the same conditions that are considered when evaluating motifs identified in homologous proteins.

Using a training set consisting of 32 sequences from the 10 experimentally-proven dependence receptors ([Table 1](#pone-0000463-t001){ref-type="table"}), we identified a novel motif that occurs in all of the training set proteins. This motif, designated "DART" (dependence-associated receptor transmembrane) motif, appeared in the transmembrane region of all proteins in the training set that include a transmembrane region, whereas it appeared in the ligand-binding region of the one protein that lacks a transmembrane region (the androgen receptor).

The consensus sequence of the proposed DART domain is shown in [Figure 1](#pone-0000463-g001){ref-type="fig"}, and the DART motifs from the training set proteins are aligned in [Figure 2](#pone-0000463-g002){ref-type="fig"}.

![Multilevel consensus sequence and amino acid frequency of the DART motif.\
MEME motifs are represented by position-specific probability matrices that specify the probability of each possible letter appearing at each possible position in an occurrence of the motif. In order to make it easier to see which letters are most likely in each of the columns of the motif, the simplified motif shows the letter probabilities multiplied by 10 rounded to the nearest integer. Zeros are replaced by ":" (a colon) for readability. The information content diagram provides an idea of which positions in the motif are most highly conserved. Each column (position) in a motif can be characterized by the amount of information it contains (measured in bits). Highly conserved positions in the motif have high information; positions where all letters are equally likely have low information. The diagram is printed so that each column lines up with the same column in the simplified position-specific probability matrix above it. This multilevel consensus sequence says several things about the motif. First, the most likely form of the motif can be read from the top line as LLVIAVVVALVIxVLLVxL. Second, that only letter L has probability more than 0.2 in position 1 of the motif, both L and I have probability greater than 0.2 in position 2, etc. Third, a rough approximation of the motif can be made by converting the multilevel consensus sequence into the Prosite signature: L-\[LI\]-V-I-\[AS\]-V-V-V-\[AGS\]-L-V-\[IF\]-x-\[VI\]-L-\[LV\]-V-x-\[LI\].](pone.0000463.g001){#pone-0000463-g001}

![Aligned DART motif within all dependence receptor training set members.\
Occurrences (sites) of the DART motif within the sequences of the 32 dependence receptors that were used as the training set. The sites are shown aligned with each other, and the ten sequence positions preceding and following each site are also shown. Each site is identified by the name of the sequence where it occurs and the position in the sequence where the site begins. The sites are listed in order of increasing p-value (decreasing statistical significance). The p-value of a site is computed from the match score of the site with the position specific scoring matrix for the motif. The p-value gives the probability of a random string (generated from the background letter frequencies) having the same match score or higher. Amino acid residues constituting the transmembrane region of the protein are indicated by shading.](pone.0000463.g002){#pone-0000463-g002}

Using the software program MAST to search the Swiss-Prot database for other proteins that displayed the DART motif, we found an additional 54 sequences, 16 of which are human proteins (using a cut-off at E-value of 2.7, the value below which all training set members scored) ([Table 2](#pone-0000463-t002){ref-type="table"}). Of 13,991 human proteins in the database, 3,465 are annotated as transmembrane proteins, and 25 display the DART motif---nine of the 10 training set members (the exception being, as noted above, the androgen receptor) and 16 additional human proteins ([Table 3](#pone-0000463-t003){ref-type="table"}). Of these 16 additional proteins, all were transmembrane proteins, and all contained the DART motif within their transmembrane region. Thus the DART motif is relatively uncommon (at least as defined here), occurring in approximately 0.7% of human transmembrane proteins (25/3465). If we include slightly less similar motifs, extending the acceptable E-value from 2.7 to 10, then an additional 4 human proteins are included (data not shown). The alignment of the putative DART domains of these 16 human non-training set proteins is shown in [Figure 3](#pone-0000463-g003){ref-type="fig"}. A dendrogram of the human DART motifs is shown in [Figure 4](#pone-0000463-g004){ref-type="fig"}.

![Aligned DART motif within 26 human proteins.\
Occurrences (sites) of the DART motif within the sequences of the 10 human dependence receptors from the training set (top 10 of list) and the 16 human proteins designated by MAST as containing the motif. The sites are shown aligned with each other, and the ten sequence positions preceding and following each site are also shown. Each site is identified by the name of the sequence where it occurs and the position in the sequence where the site begins. The sites are listed in order of increasing p-value. The p-value of a site is computed from the match score of the site with the position specific scoring matrix for the motif. The p-value gives the probability of a random string (generated from the background letter frequencies) having the same match score or higher. Amino acid residues constituting the transmembrane region of the protein are indicated by shading.](pone.0000463.g003){#pone-0000463-g003}

![Dendrogram of the 26 human DART-containing proteins.\
Dendrogram demonstrating the relationships of the DART motif sequences within each of the 26 human proteins found to contain DART (10 from the training set plus 16 discovered through the use of MAST).](pone.0000463.g004){#pone-0000463-g004}

10.1371/journal.pone.0000463.t002

###### MAST result list of 54 non-training set proteins found to display the DART motif.

![](pone.0000463.t002){#pone-0000463-t002-2}

  Swiss-Prot Accession \# / Sequence Name      Protein Name (truncated)
  ----------------------------------------- ------------------------------
  sp\|Q05910\|ADAM8_MOUSE                    ADAM 8 precursor (A disin...
  sp\|Q06335\|APLP2_MOUSE                    Amyloid-like protein 2 pr...
  sp\|Q06481\|APLP2_HUMAN                    Amyloid-like protein 2 pr...
  sp\|P15943\|APLP2_RAT                      Amyloid-like protein 2 pr...
  sp\|Q9JKC6\|BM88_MOUSE                             BM88 antigen
  sp\|Q8N111\|BM88_HUMAN                             BM88 antigen
  sp\|Q29026\|BM88_PIG                               BM88 antigen
  sp\|P21964\|COMT_HUMAN                     Catechol O-methyltransfer...
  sp\|Q12215\|WSC3_YEAST                     Cell wall integrity and s...
  sp\|P22521\|IMMV_ECOLI                     Colicin V immunity protei...
  sp\|P18466\|HA19_CANFA                     DLA CLASS I HISTOCOMPATIB...
  sp\|P54753\|EPHB3_HUMAN                    Ephrin type-B receptor 3 ...
  sp\|Q07498\|EPHB3_CHICK                    Ephrin type-B receptor 3 ...
  sp\|Q91735\|EPHB3_XENLA                    Ephrin type-B receptor 3 ...
  sp\|P54761\|EPHB4_MOUSE                    Ephrin type-B receptor 4 ...
  sp\|P04855\|FUS_SENDZ                      Fusion glycoprotein F0 pr...
  sp\|P18345\|VGLE_EHV4                             Glycoprotein E
  sp\|P32343\|YKM4_YEAST                     Hypothetical 65.1 kDa pro...
  sp\|O13785\|YEO7_SCHPO                     Hypothetical protein C17G...
  sp\|Q21874\|YF1M_CAEEL                     Hypothetical protein R09E...
  sp\|Q83S36\|YBHG_SHIFL                     Hypothetical UPF0194 memb...
  sp\|Q8FJN6\|YBHG_ECOL6                     Hypothetical UPF0194 memb...
  sp\|P75777\|YBHG_ECOLI                     Hypothetical UPF0194 memb...
  sp\|Q8X7Y9\|YBHG_ECO57                     Hypothetical UPF0194 memb...
  sp\|P78552\|I13R1_HUMAN                    Interleukin-13 receptor a...
  sp\|P16150\|LEUK_HUMAN                     Leukosialin precursor (Le...
  sp\|P50895\|LU_HUMAN                       Lutheran blood group glyc...
  sp\|P32334\|MSB2_YEAST                     MSB2 protein (Multicopy s...
  sp\|Q9HZL1\|NQRF_PSEAE                     Na(+)-translocating NADH-...
  sp\|P97798\|NEO1_MOUSE                          Neogenin precursor
  sp\|Q92859\|NEO1_HUMAN                          Neogenin precursor
  sp\|Q9UM47\|NOTC3_HUMAN                    Neurogenic locus notch ho...
  sp\|P46697\|PPIB_MYCLE                     Probable peptidyl-prolyl ...
  sp\|P50605\|SDC_CAEEL                      Probable syndecan precurs...
  sp\|P20990\|VA13_VACCC                             Protein A13
  sp\|P33838\|VA13_VARV                              Protein A13
  sp\|O15165\|C181_HUMAN                           Protein C18orf1
  sp\|Q53902\|MMLA_STRCO                     Putative membrane protein...
  sp\|P06494\|ERBB2_RAT                      Receptor tyrosine-protein...
  sp\|Q8E6G4\|EZRA_STRA3                     Septation ring formation ...
  sp\|P49415\|SDC_DROME                           Syndecan precursor
  sp\|P26260\|SDC1_RAT                       Syndecan-1 precursor (SYN...
  sp\|P18828\|SDC1_MOUSE                     Syndecan-1 precursor (SYN...
  sp\|Q64704\|STX3_MOUSE                              Syntaxin-3
  sp\|Q08849\|STX3_RAT                                Syntaxin-3
  sp\|Q13277\|STX3_HUMAN                              Syntaxin-3
  sp\|P13726\|TF_HUMAN                       Tissue factor precursor (...
  sp\|Q9D7R2\|TMEPA_MOUSE                    Transmembrane prostate an...
  sp\|O14763\|TR10B_HUMAN                    Tumor necrosis factor rec...
  sp\|Q9UBN6\|TR10D_HUMAN                    Tumor necrosis factor rec...
  sp\|P09758\|TACD2_HUMAN                    Tumor-associated calcium ...
  sp\|O70404\|VAM8_MOUSE                     Vesicle-associated membra...
  sp\|Q9WUF4\|VAM8_RAT                       Vesicle-associated membra...
  sp\|O95183\|VAM5_HUMAN                     Vesicle-associated membra...

The top-scoring non-training-set proteins displaying the DART motif, representing 38 proteins (plus 16 orthologues). Sixteen of the 54 are the human proteins listed in [Table 3](#pone-0000463-t003){ref-type="table"}.

10.1371/journal.pone.0000463.t003

###### 16 human proteins found to display the DART motif.

![](pone.0000463.t003){#pone-0000463-t003-3}

  Entry Name    Accession \#                       Protein Name                        TM Location   DART Location       Subcellular Location                                            Function (per Swiss-Prot)
  ------------ -------------- ------------------------------------------------------- ------------- --------------- ------------------------------ -----------------------------------------------------------------------------------------------------
  APLP2            Q06481              Amyloid-like protein 2 \[Precursor\]              693-716        698-716      Type I membrane protein (MP)                             May play a role in the regulation of hemostasis
  CS001            O15165                         Protein C18orf1                         65-85          67-85                Type Ib MP                                        May confer susceptibility to schizophrenia
  BM88             Q8N111                          BM88 antigen                          126-146        126-144               Type IV MP                              Involved in neuroblastoma cell differentiation (by similarity)
  NOTC3            Q9UM47            Neurogenic locus notch homolog protein 3           1644-1664      1646-1664              Type I MP             Receptor for membrane-bound ligands Jagged1, Jagged2 and Delta1 to regulate cell-fate determination
  EPHB3            P54753                    Ephrin type-B receptor 3                    560-580        559-577               Type I MP                                         Receptor for members of the ephrin-B family
  TR10B            O14763      Tumor necrosis factor receptor superfamily member 10B     211-231        213-231               Type I MP                                                 Receptor for TNFSF10/TRAIL
  I13R1            P78552              Interleukin-13 receptor alpha-1 chain             344-367        349-367               Type I MP                                               Binds IL13 with a low affinity
  TF               P13726                          Tissue factor                         252-274        254-272               Type I MP                    Initiates blood coagulation by forming a complex with circulating factor VII or VIIa
  TR10D            Q9UBN6      Tumor necrosis factor receptor superfamily member 10D     212-232        212-230               Type I MP                                                     Receptor for TRAIL
  LU               P50895                Lutheran blood group glycoprotein               548-568        551-569               Type I MP             Probable receptor. May mediate intracellular signaling. Member of the immunoglobulin superfamily IG
  STX3             Q13277                           Syntaxin-3                           264-284        264-282               Type IV MP                     Potentially involved in docking of synaptic vesicles at presynaptic active zones
  VAMP5            O95183              Vesicle-associated membrane protein 5              73-93          75-93                Type IV MP                         May participate in trafficking events that are associated with myogenesis
  COMT             P21964                  Catechol O-methyltransferase                   7-26           7-25                 Type II MP                   Catalyzes the O-methylation of catecholamine neurotransmitters and catechol hormones
  LEUK             P16150                           Leukosialin                          254-276        255-273               Type I MP.                            Physicochemical properties of the T-cell surface and lectin binding
  NEO1             Q92859                            Neogenin                           1106-1126      1104-1122              Type I MP                                          Receptor for repulsive guidance molecule
  TACD2            P09758          Tumor-associated calcium signal transducer 2          275-297        277-295               Type I MP                                           May function as growth factor receptor

Sixteen human proteins were discovered that display high-scoring matches for the DART motif when the Swiss-Prot database was searched using the MAST software program. [Table 3](#pone-0000463-t003){ref-type="table"} shows the transmembrane location and the location of the DART motif. Data taken from the Swiss-Prot database. All accession numbers are from Swiss-Prot.

Structure of the putative DART domain {#s3b}
-------------------------------------

The predicted secondary structure of the consensus DART domain, as predicted by the SOPMA (Self Optimized Prediction Method from Alignments) method [@pone.0000463-Combet1] is for a helical structure ([Figure 5](#pone-0000463-g005){ref-type="fig"}). This is not surprising, given that the motif lies within the transmembrane region of the proteins that display it. However, in comparison to other transmembrane regions (in randomly selected transmembrane proteins) it is valine rich (29±4% vs. 15±3%; p\<0.001).

![Predicted secondary structure of the consensus sequence of DART.\
SOPMA analysis demonstrates the alpha-helical nature of the putative DART domain.](pone.0000463.g005){#pone-0000463-g005}

Discussion {#s4}
==========

The function of this novel motif is currently unknown. The finding that it exists in all dependence receptors described to date suggests that it may play a role in some biochemical process related to their function, such as the induction of apoptosis or the inhibition of apoptosis following ligand binding, or possibly an interaction with another membrane protein or membrane-associated non-proteinaceous molecule such as a lipid. For at least three of the proteins in the training set---APP, p75NTR, and DCC---this region undergoes regulated intramembrane proteolysis (RIP) [@pone.0000463-Brown1], releasing an intracytoplasmic fragment that may migrate to the nucleus. Thus it is possible that the other proteins that display the DART motif may be substrates that also undergo regulated intramembrane proteolysis; however, a number of proteins that have been shown to undergo such cleavage do not display a DART motif, so it is clearly not required for such processing.

It is noteworthy that the transmembrane regions of DART-containing proteins are valine rich, with nearly twice the percentage of valine residues present in randomly-selected human Type I transmembrane protein domains (29±4% vs. 15±3%; p\<0.001). It has been shown that Leu heptads within transmembrane domains may serve as homomultimerization domains and that the substitution of Ala (or other residues typical of transmembrane regions, including Val) for Leu may prevent homomultimerization [@pone.0000463-Gurezka1]. Thus one possibility for the Val-rich nature of the DART domain may relate to the inhibition of receptor homomultimerization.

Proteins identified by MAST as displaying the DART motif {#s4a}
--------------------------------------------------------

As noted above, MAST identified 16 proteins, all transmembrane proteins displaying the DART motifs and were as similar to the consensus as those of the training set ([Table 3](#pone-0000463-t003){ref-type="table"}; [Figure 3](#pone-0000463-g003){ref-type="fig"}). Most of these have been implicated in cell death, either directly or indirectly; furthermore, several bind trophic ligands, as well, making them reasonable candidates to evaluate experimentally as possible dependence receptors.

Neogenin has recently been shown to bind RGM (repulsive guidance molecule), and to serve as a possible dependence receptor for RGM, inducing programmed cell death that is inhibited by RGM [@pone.0000463-Matsunaga1]. Therefore, the identification of a DART motif within neogenin provides further support for RGM as a candidate dependence receptor.

APLP2 (APP-like protein 2) has been shown previously to be similar to APP in displaying a potential caspase-cleavage site in its intracytoplasmic domain [@pone.0000463-Galvan1]. Cleavage at this site liberates a pro-apoptotic peptide, C31, similar to what has been demonstrated for APP. Thus, although it is not yet clear whether APLP2 functions as a dependence receptor, and in particular whether APLP2 binds a trophic ligand, by analogy to APP it may bind laminin, collagen IV, glypican, or another ligand [@pone.0000463-Beher1]--[@pone.0000463-Williamson1], and thus serve as a dependence receptor for one or more of those ligands.

Notch is an extensively-studied transmembrane receptor involved in cell fate determination. It binds to ligands Delta1, Jagged1, and Jagged2, regulating differentiation, proliferation, and apoptosis. Notch, like APP, DCC, and p75NTR, undergoes regulated intramembrane proteolysis, liberating an intracytoplasmic domain, the NICD, that forms a transcriptional activator complex with RBP-J kappa, activating genes of the enhancer of split locus.

Ephrin type B receptor 3 binds both ephrin-B1 and ephrin-B2. It is not yet known whether this receptor induces programmed cell death in the absence of ephrin-B1 or --B2 binding.

Tumor-associated calcium signal transducer 2 (TACD2) may function as a trophic factor receptor, but its ligand is currently unknown.

Three of the proteins identified by MAST as displaying a DART motif are involved in neurotransmitter synthesis or release. Catechol O-methyltransferase exists in both cytosolic and membrane-spanning (type II membrane protein) forms, and this latter displays a DART motif. Syntaxin-3 is a Type IV membrane protein potentially involved in docking of synaptic vesicles at presynaptic active zones. Vesicle-associated membrane protein 5 (VAMP5) is also a Type IV membrane protein that may participate in vesicle trafficking events associated with myogenesis.

Conclusion {#s4b}
----------

Ten of ten previously described dependence receptors display a region of similarity dubbed the DART (dependence-associated receptor transmembrane) motif. MAST identified this motif in an additional 16 human proteins in the SwissProt database, in all cases in the transmembrane regions. The function of this novel putative domain is unknown, but the motif is noted to be valine rich, and in at least four cases, the DART motif is a site of regulated intramembrane proteolysis (RIP). Whether or not this motif plays a functional role in cell death induction or ligand-induced inhibition mediated by dependence receptors remains to be determined, but the identification of this motif in 16 non-training-set proteins such as Notch and APLP2 raises the question of whether these proteins may also function as dependence receptors. Since the field of dependence receptors is an emerging field, we have developed a website for predicting dependence receptors at <http://bis.ifc.unam.mx/DependenceReceptors/>.

We thank Professor Mark Van der Laan (University of California, Berkeley, and the Buck Institute for Age Research) for his helpful discussions and assistance with data analysis.

**Competing Interests:**The authors have declared that no competing interests exist.

**Funding:**This work was supported by a grant to the Buck Institute from American Bioscience, Inc., by NIH grants NS45093, AG12282 and NS33376 to DEB and by CoNaCyT grant SEP-2004-C01-47399/A-1 to GDR.

[^1]: Conceived and designed the experiments: Gd DB DK. Performed the experiments: Gd. Analyzed the data: Gd DK KB. Wrote the paper: Gd DB DK KB. Other: Proposed the original idea and performed the initial computational analysis described in this work: Gd. Participated in the design and coordination of the study and helped to draft and finalize the manuscript: DB. Read and approved the final manuscript: DB Gd DK KB. Participated in the computational analysis and in the preparation of the manuscript: DK. Participated in the computation analysis: KB.

[^2]: Current address: Universidad Nacional Autonoma de Mexico/Instituto de Fisiologia Celular, Biochemistry Department, Ciudad Universitaria, Mexico
